scorecardresearch
Clear all

Stock Analysis

View More

LATEST NEWS

View More
News
MARKETS
Dr Reddys Laboratories Ltd

Feedback
Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd (DRREDDY) Share Price

  • Sector: Pharmaceuticals (Large Cap)
  • Volume: 789,989
Mar 20, 2023 15:52 IST-
  • NSE
  • BSE
₹4,439.45
₹3.30 (0.07%)
  • Share
  • Whatsapp
  • Twitter
  • Facebook
₹4422.5 Low
Today’s Performance
₹4494 High
₹3789.85 Low
52 Week’s Performance
₹4645 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 0.07%
  • 1 Week 0.92%
  • 1 Month -1.65%
  • 3 Months 0.91%
  • 6 Months 8.22%
  • 1 Year 9.75%
  • 3 Years 16.84%
  • 5 Years 15.92%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 5.00
  • Beta 0.48
  • 52-Week Low (₹) 3,789.85
  • 52-Week High (₹) 4,645.00
  • Price-to-Book (X)* 3.55
  • Dividend Yield (%) 0.68
  • Price-to-Earnings (P/E) (X)* 20.27
  • Earnings Per Share (₹) 218.83
  • Sector Price Earning (X)* 26.41
  • Market Cap (₹ Cr.)* 73,873.90
  • * Vaues as of last close price

COMPETITORS

Top Stories

BT TV

thumb 25:18 Business Resilience Conversation | Crisis Compass- Surviving Lows & Lockdowns
Thumb 6:58 J&K Gets Its First FDI Project
thumb 41:32 The India Moment: The Big Finale Of The India Today Conclave 2023
thumb 44:02 We Are Using AI To Transform The Indian Judiciary System: CJI D.Y. Chandrachud
thumb 14:52 India Is Bound To Become Edtech Capital Of The World: Byju’s Co-Founder Divya Gokulnath
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

Aug 08, 2022 Sell
Dr. Reddys Lab Ltd ,ISHARES INDIA MAURITIUS CO
  • Qty 19329
  • Average Price ₹4,156.85
Aug 08, 2022 Sell
Dr. Reddys Lab Ltd ,ISHARES INDIA INDEX MAURITIUS COMPANY
  • Qty 137595
  • Average Price ₹4,156.85
Aug 08, 2022 PURCHASE
Dr. Reddys Lab Ltd ,ISHARES MSCI INDIA ETF
  • Qty 137595
  • Average Price ₹4,156.85
Aug 08, 2022 PURCHASE
Dr. Reddys Lab Ltd ,ISHARES INDIA 50 ETF
  • Qty 19329
  • Average Price ₹4,156.85
Nov 03, 2022 Sell
Dr. Reddys Lab Ltd ,ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 180718
  • Average Price ₹4,555.65
Nov 03, 2022 PURCHASE
Dr. Reddys Lab Ltd ,ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 180718
  • Average Price ₹4,555.65
Nov 14, 2022 Sell
Dr. Reddys Lab Ltd ,ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 180717
  • Average Price ₹4,539.45
Nov 14, 2022 PURCHASE
Dr. Reddys Lab Ltd ,ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 180717
  • Average Price ₹4,539.45
May 04, 2022 Sell
DRREDDY ,ISHARES CORE TOTAL INTERNATIONAL STOCK MAURITIUS CO
  • Qty 136855
  • Average Price ₹4,123.90
May 04, 2022 PURCHASE
DRREDDY ,ISHARES CORE MSCI TOTAL INTERNATIONAL STOCK ETF
  • Qty 136855
  • Average Price ₹4,123.90
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Jun 16, 2016 PURCHASE
Dr. Reddys Lab Ltd ,DR REDDYS LABORATORIES LIMITED
  • Qty 884213
  • Average Price ₹3,076.83
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

FAQ’S

What was Dr Reddys Laboratories Ltd share price previously?
Dr Reddys Laboratories Ltd share price was up by 0.07% from the previous closing price of ₹4,436.15.
Who are peers of Dr Reddys Laboratories Ltd?
The peers of Dr Reddys Laboratories Ltd are Syngene International Ltd, Glaxosmithkline Pharmaceuticals Ltd, Ipca Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, Divis Laboratories Ltd, Cipla Ltd, J B Chemicals & Pharmaceuticals Ltd, Gland Pharma Ltd, Alkem Laboratories Ltd, Aurobindo Pharma Ltd, Biocon Ltd, Lupin Ltd, Laurus Labs Ltd, Sun Pharmaceuticals Industries Ltd.
Who is/are the promoter/promoters of Dr Reddys Laboratories Ltd?
The promotor/promotors of Dr Reddys Laboratories Ltd are G V Prasad, K Satish Reddy, Kalpana Morparia, Bruce L A Carter, Sridar Iyengar, Shikha Sanjaya Sharma, Leo Puri, K P Krishnan, Pennv Wan, K Randhir Singh.
What has been 52-week high of Dr Reddys Laboratories Ltd stocks?
The highest price of Dr Reddys Laboratories Ltd stock is ₹4,645.00 in the last 52-week.

ABOUT DR REDDY'S LABS

Dr Reddys Laboratories Ltd, incorporated in the year 1984, has its registered office in 8-2-337 Road No 3, Banjara Hills, Hyderabad, Telangana, 500034, 91-40-49002900, 91-40-49002999, . The main industry in which Dr Reddys Laboratories Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Dr Reddys Laboratories Ltd is/are S R Batliboi & Associates LLP. In the main management, K Satish Reddy is chairman and K Randhir Singh is the company secretary for Dr Reddys Laboratories Ltd.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.